Poseida Therapeutics Stock Price To Earnings To Growth
Poseida Therapeutics fundamentals help investors to digest information that contributes to Poseida Therapeutics' financial success or failures. It also enables traders to predict the movement of Poseida Stock. The fundamental analysis module provides a way to measure Poseida Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Poseida Therapeutics stock.
Poseida |
Poseida Therapeutics Company Price To Earnings To Growth Analysis
Poseida Therapeutics' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Poseida Therapeutics Price To Earnings To Growth | (0.63) X |
Most of Poseida Therapeutics' fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Poseida Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Poseida Therapeutics has a Price To Earnings To Growth of -0.63 times. This is 188.73% lower than that of the Biotechnology sector and 120.06% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 112.88% higher than that of the company.
Poseida Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Poseida Therapeutics' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Poseida Therapeutics could also be used in its relative valuation, which is a method of valuing Poseida Therapeutics by comparing valuation metrics of similar companies.Poseida Therapeutics is currently under evaluation in price to earnings to growth category among its peers.
Poseida Fundamentals
| Return On Equity | -0.58 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.40) % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 777.81 M | |||
| Shares Outstanding | 97.47 M | |||
| Shares Owned By Insiders | 27.64 % | |||
| Shares Owned By Institutions | 58.44 % | |||
| Number Of Shares Shorted | 3.59 M | |||
| Price To Earning | 214.00 X | |||
| Price To Book | 10.62 X | |||
| Price To Sales | 6.14 X | |||
| Revenue | 64.7 M | |||
| Gross Profit | (21.57 M) | |||
| EBITDA | (109.04 M) | |||
| Net Income | (123.43 M) | |||
| Cash And Equivalents | 142.56 M | |||
| Cash Per Share | 1.66 X | |||
| Total Debt | 85.42 M | |||
| Debt To Equity | 1.39 % | |||
| Current Ratio | 3.69 X | |||
| Book Value Per Share | 0.90 X | |||
| Cash Flow From Operations | (92.17 M) | |||
| Short Ratio | 1.49 X | |||
| Earnings Per Share | (0.63) X | |||
| Price To Earnings To Growth | (0.63) X | |||
| Target Price | 9.5 | |||
| Number Of Employees | 350 | |||
| Beta | 0.54 | |||
| Market Capitalization | 925.93 M | |||
| Total Asset | 273.88 M | |||
| Retained Earnings | (594.29 M) | |||
| Working Capital | 155.16 M | |||
| Current Asset | 10.59 M | |||
| Current Liabilities | 5.1 M | |||
| Net Asset | 273.88 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Poseida Stock
If you are still planning to invest in Poseida Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poseida Therapeutics' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |